相似文献
1
Educating health professionals about drug and device promotion: advocates' recommendations.
PLoS Med. 2006 Nov;3(11):e451. doi: 10.1371/journal.pmed.0030451.
2
Educating health professionals about drug and device promotion: a Nepalese perspective.
PLoS Med. 2007 Feb;4(2):e89; author reply e88. doi: 10.1371/journal.pmed.0040089.
3
Promotion of drugs and devices at international conferences held in Canada.
Health Law Can. 2009 Oct;30(1):16-8.
4
Relationships with the drug industry: More regulation, greater transparency.
BMJ. 2009 Feb 3;338:b211. doi: 10.1136/bmj.b211.
5
Educating health care professionals to care for patients with disabilities.
JAMA. 2009 Sep 23;302(12):1334-5. doi: 10.1001/jama.2009.1398.
6
Distance learning for health professionals' education.
J Indian Med Assoc. 1997 Jul;95(7):407-9.
7
Getting it right: educating professionals to work together in improving health and health care.
J Interprof Care. 2008 Aug;22(4):364-74. doi: 10.1080/13561820802227871.
8
An educationist teaching healthcare professionals?
Natl Med J India. 2009 May-Jun;22(3):163-4.
9
Transforming health professionals' education.
Lancet. 2011 Apr 9;377(9773):1237; author reply 1238-9. doi: 10.1016/S0140-6736(11)60498-4.
10
Direct-to-consumer advertising--education or emotion promotion?
N Engl J Med. 2002 Feb 14;346(7):524-6. doi: 10.1056/NEJM200202143460713.
引用本文的文献
1
Assessing the effect of educational intervention on pharmaceutical promotion: a follow-up study among medical students from Pakistan.
BMC Med Educ. 2025 Aug 26;25(1):1199. doi: 10.1186/s12909-025-07725-3.
2
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.
PLoS One. 2023 Aug 28;18(8):e0290603. doi: 10.1371/journal.pone.0290603. eCollection 2023.
3
A follow-up study on the effects of an educational intervention against pharmaceutical promotion.
PLoS One. 2020 Oct 28;15(10):e0240713. doi: 10.1371/journal.pone.0240713. eCollection 2020.
4
Assessment of a Pharmaceutical Advertisement Analysis Module in a Drug Literature Evaluation Course.
Am J Pharm Educ. 2017 Aug;81(6):112. doi: 10.5688/ajpe816112.
5
Professionalism perspectives among medical students of a novel medical graduate school in Malaysia.
Adv Med Educ Pract. 2016 Jul 25;7:407-22. doi: 10.2147/AMEP.S90737. eCollection 2016.
6
Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.
J Health Commun. 2015;20(11):1330-6. doi: 10.1080/10810730.2015.1018649. Epub 2015 Jul 15.
7
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
PLoS Med. 2010 Oct 19;7(10):e1000352. doi: 10.1371/journal.pmed.1000352.
8
A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
Dtsch Arztebl Int. 2010 Jun;107(22):392-8. doi: 10.3238/arztebl.2010.0392. Epub 2010 Jun 4.
9
"We noticed that suddenly the country has become full of MRI". Policy makers' views on diffusion and use of health technologies in Iran.
Health Res Policy Syst. 2010 Apr 6;8:9. doi: 10.1186/1478-4505-8-9.
10
Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research.
Open Trop Med J. 2008;1:92-100. doi: 10.2174/1874315300801010092.
本文引用的文献
1
Awareness and attitudes about disease mongering among medical and pharmaceutical students.
PLoS Med. 2006 Apr;3(4):e213. doi: 10.1371/journal.pmed.0030213. Epub 2006 Apr 11.
2
What are the public health effects of direct-to-consumer drug advertising?
PLoS Med. 2006 Mar;3(3):e145. doi: 10.1371/journal.pmed.0030145. Epub 2006 Mar 28.
3
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.
JAMA. 2006 Jan 25;295(4):429-33. doi: 10.1001/jama.295.4.429.
4
Banning all drug promotion is the best option pending major reforms.
J Bioeth Inq. 2005;2(2):75-81. doi: 10.1007/BF02448846.
5
Pharmacists' perceptions of the pharmaceutical industry.
Am J Health Syst Pharm. 2005 Nov 15;62(22):2401-9. doi: 10.2146/ajhp050073.
6
Who's buying lunch: are gifts to surgeons from industry bad for patients?
Thorac Surg Clin. 2005 Nov;15(4):533-42. doi: 10.1016/j.thorsurg.2005.06.004.
7
Medical students' exposure to and attitudes about drug company interactions: a national survey.
JAMA. 2005 Sep 7;294(9):1034-42. doi: 10.1001/jama.294.9.1034.
8
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care.
Schizophr Res. 2005 Sep 1;77(1):107-9. doi: 10.1016/j.schres.2005.02.001.
9
The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
Acad Psychiatry. 2005 May-Jun;29(2):222-9. doi: 10.1176/appi.ap.29.2.222.
10
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.
Lancet. 2005;365(9458):475-81. doi: 10.1016/S0140-6736(05)17864-7.
Zotero 插件